GLP-1 medications, widely known for weight loss, may evolve into primary prevention drugs akin to aspirin, according to Dr. Furkan Barack. Beyond their established benefits for sleep apnea and heart attack reduction, these drugs show promise in improving Alzheimer's disease in animal models and redu
A new therapeutic, brensocatib, shows promise in treating non-cystic fibrosis (non-CF) bronchiectasis by inhibiting serine proteases, notably neutrophil elastase. The drug is expected to be most effective in patients with highly metabolically active neutrophils, which contribute to the disease's sym
Dr. Rox Anderson announced breakthroughs in pain control and genetic disease treatment. A novel injectable ice formulation, originating from research into lipid sensitivity to cold, offers a three-month nerve block for chronic pain relief. Concurrently, a clinical trial showed that deoxyolate, an FD